CY1116752T1 - Μεθοδος παρασκευης για αμορφη λερκανιδιπινη - Google Patents

Μεθοδος παρασκευης για αμορφη λερκανιδιπινη

Info

Publication number
CY1116752T1
CY1116752T1 CY20151100794T CY151100794T CY1116752T1 CY 1116752 T1 CY1116752 T1 CY 1116752T1 CY 20151100794 T CY20151100794 T CY 20151100794T CY 151100794 T CY151100794 T CY 151100794T CY 1116752 T1 CY1116752 T1 CY 1116752T1
Authority
CY
Cyprus
Prior art keywords
organic solvent
lercanidipine
lerkanidipin
american
preparation
Prior art date
Application number
CY20151100794T
Other languages
English (en)
Inventor
So Mi Choo
Hong Joo Ha
Jung Gi An
Won Jung Lee
S G Lee
Young-Seok Byun
Young Ii Moon
Of Korea Republic
Original Assignee
Recordati Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Limited filed Critical Recordati Ireland Limited
Publication of CY1116752T1 publication Critical patent/CY1116752T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μια μέθοδο για παρασκευή άμορφης λερκανιδιπίνης και, περισσότερο δε ειδικότερα, με μια μέθοδο παρασκευής άμορφης λερκανιδιπίνης περιλαμβάνοντας τα βήματα: 1) της διάλυσης της λερκανιδιπίνης σε έναν οργανικό διαλύτη για τον σχηματισμό ενός διαλύματος• (2) του σχηματισμού ιζημάτων ενσταλάζοντας το διάλυμα μέσα σε έναν οργανικό διαλύτη που επιλέγεται από την ομάδα συνιστάμενη από κυκλοεξάνιο, κυκλοπεντάνιο, εξάνιο, και πετρελαϊκό αιθέρα και αναδεύοντας• (3) της διήθησης των ιζημάτων, πλύσης με τον οργανικό διαλύτη που χρησιμοποιείται στο βήμα 2 και ξήρανσης κενού. Σύμφωνα με την παρούσα εφεύρεση, η άμορφη λερκανιδιπίνη έχοντας μια εξαιρετική διαλυτότητα και βιοδιαθεσιμότητα μπορεί να παρασκευαστεί σε υψηλή καθαρότητα και απόδοση ελέγχοντας καταλλήλως τους μείζονες διαλύτες και τον λόγο όγκων αυτών.
CY20151100794T 2004-10-27 2015-09-14 Μεθοδος παρασκευης για αμορφη λερκανιδιπινη CY1116752T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040086179 2004-10-27
KR1020050031041A KR100651212B1 (ko) 2004-10-27 2005-04-14 무정형 레르카니디핀의 제조방법
EP05817765.0A EP1858851B1 (en) 2004-10-27 2005-10-26 Preparing method for amorphous lercanidipine

Publications (1)

Publication Number Publication Date
CY1116752T1 true CY1116752T1 (el) 2017-03-15

Family

ID=36228043

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100794T CY1116752T1 (el) 2004-10-27 2015-09-14 Μεθοδος παρασκευης για αμορφη λερκανιδιπινη

Country Status (13)

Country Link
EP (1) EP1858851B1 (el)
KR (1) KR100651212B1 (el)
CA (1) CA2624934C (el)
CY (1) CY1116752T1 (el)
DK (1) DK1858851T3 (el)
ES (1) ES2546930T3 (el)
HR (1) HRP20150989T1 (el)
HU (1) HUE025506T2 (el)
PL (1) PL1858851T3 (el)
PT (1) PT1858851E (el)
RS (1) RS54174B1 (el)
SI (1) SI1858851T1 (el)
WO (1) WO2006046830A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
US20100104649A1 (en) * 2007-03-05 2010-04-29 Actavis Group Ptc Ehf Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US5696139A (en) 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5912351A (en) 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
ITMI20011727A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen

Also Published As

Publication number Publication date
EP1858851A1 (en) 2007-11-28
EP1858851A4 (en) 2009-12-30
HRP20150989T1 (hr) 2015-10-23
EP1858851B1 (en) 2015-06-24
CA2624934A1 (en) 2006-05-04
HUE025506T2 (en) 2016-02-29
RS54174B1 (en) 2015-12-31
KR100651212B1 (ko) 2006-12-01
PT1858851E (pt) 2015-10-12
PL1858851T3 (pl) 2015-11-30
KR20060045705A (ko) 2006-05-17
CA2624934C (en) 2013-04-23
SI1858851T1 (sl) 2015-11-30
ES2546930T3 (es) 2015-09-30
WO2006046830A1 (en) 2006-05-04
DK1858851T3 (en) 2015-09-14

Similar Documents

Publication Publication Date Title
CY1116752T1 (el) Μεθοδος παρασκευης για αμορφη λερκανιδιπινη
Kalaitzakis et al. Photooxygenation of furylalkylamines: Easy access to pyrrolizidine and indolizidine scaffolds
JP2010525122A5 (el)
BR0309659A (pt) Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
NO20080358L (no) Fremgangsmater og sammensetninger for a fremstille negative-sense virus RNA i hundedyrceller
CN111875602B (zh) 一种氰基修饰吡啶并咪唑类衍生物及其制备方法和应用
JP2007514047A5 (el)
JP2014148663A5 (el)
CN103539725B (zh) 四芳基芘类衍生物、制备方法和应用及电致发光器件
JP2015506403A5 (el)
CN103242298A (zh) 1,2,4-三氮唑类衍生物及其制备方法和应用及有机电致发光器件
CN111303010A (zh) 一种含酰亚胺结构的有机室温磷光材料、制备方法及其应用
CN108569970B (zh) 联苯二胺型的三芳胺化合物及包含其的有机电致发光器件
CN106699735A (zh) 三唑化合物及发光器件
CN109734649B (zh) 一种基于芳酰亚胺的有机小分子高效室温磷光材料及其制备与应用
CN104629721A (zh) 一种性能优良的有机发光材料及其制备方法
JP2009137961A5 (el)
CN106749293A (zh) 一种杂环衍生物及使用该杂环衍生物的有机发光器件
CN112079805A (zh) 一种三氟甲基色酮类化合物的制备方法
AU2003236705A1 (en) Method for converting perylen-3,4:9,10-tetracarboxylic acid diimides into a form suitable for use as a fluorescent dye
KR102422398B1 (ko) 축합 다환 화합물 및 그 제조방법과 용도
DE602006004403D1 (de) Verfahren zur Herstellung von Carvedilol
CN108822040B (zh) 一种基于菲并咪唑的有机橙光小分子、制备方法及其在电致发光器件中的应用
CN104447447A (zh) 一个新的化合物及其制备方法和消除方法
JP2006117593A (ja) 新規蛍光性化合物およびその製造方法